Our proprietary strain collection, which has grown to more than 25,000 microbes – is one of the largest in the industry.

Athenix scientists improve strain production of proteins and secondary metabolites using mutagenesis, directed evolution, microbial biotechnology and genetic engineering.

Athenix also uses proprietary protein improvement strategies to alter or substantially enhance the activities of proteins identified by MiDAS or screening. This combined strategy of discovery and improvement allows us to deliver proteins with new and potent activities.